Fractus’ groundbreaking antenna technology now ventures into the realm of healthcare. The company has successfully developed an innovative wireless implantable device technology, revolutionizing the way doctors remotely monitor their patients and boosting the uptake of telehealth services by leveraging wireless connectivity. With the ability to offer real-time data and feedback, this cutting-edge technology is set to greatly improve patient care, enabling doctors to make timely, informed decisions and fostering personalized consultations that actively engage patients in their treatment journeys.
According to the American Heart Association, there is around 92,1 million adults in the US suffering from cardiovascular diseases, with nearly 500.000 cardiac pacemakers being given to patients in the US annually. The cardiac rhythm management devices market size was valued at $10,2 billion in 2018 and is expected to grow more than 4.2% CAGR to 2025 globally, being the US market value at $6,3 billion in 2025.
Fractus, a pioneering company in the field of antenna technology, has been at the forefront of revolutionizing telecommunications for over two decades. With its innovative technologies applied across various sectors, the company has left a significant imprint on society. Founded in 1999 in Barcelona, Spain, Fractus has spearheaded groundbreaking advancements, transforming the telecommunications industry. Notably, the company eliminated the need for external antennas in mobile phones, enabling worldwide connectivity while maintaining sleek designs.
